Cite
HARVARD Citation
Stranzenbach, R. et al. (2017). Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature. British journal of dermatology. pp. 1503-1509. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stranzenbach, R. et al. (2017). Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature. British journal of dermatology. pp. 1503-1509. [Online].